Deeter Investments’s AC Immune ACIU Stock Holding History

Deeter Investments’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100,000	Closed	-$275K	–	98
2026 Q1	$275K	Hold	100,000	–	–	0.03%	96
2025 Q4	$314K	Buy	+100,000	New	+$315K	0.07%	82

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Deeter Investments's ACIU Position: Q2 2026 in Review

Deeter Investments sold out of AC Immune (ACIU) in Q2 2026, closing a stake of 100,000 shares — an estimated $275K sold.

Deeter Investments first reported a position in ACIU in Q4 2025 and held it in 2 quarters. The position peaked at $314K in Q4 2025. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

Deeter Investments reported no remaining AC Immune position as of Q2 2026 after selling out during the quarter.
Deeter Investments sold 100,000 AC Immune shares in Q2 2026, an estimated $275K.
Deeter Investments first reported a position in AC Immune in Q4 2025 and held it in 2 quarters.
Deeter Investments's AC Immune position peaked at $314K in Q4 2025.
43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Deeter Investments's 13F filing for Q2 2026, filed 8 Oct 2026.